semaglutide with cagrilintide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study contour smartmedicine #bpc157 #fda #evidencebasedmedicine Specification:10 mg vial

semaglutide with cagrilintide Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study contour smartmedicine #bpc157 #fda #evidencebasedmedicine Specification:10 mg vial

smartmedicine #bpc157 #fda #evidencebasedmedicine #orthopedics #peptides #healthcareinnovation #followthefro | Scott Sigman MD

Do not freeze, as this may compromise stability and effectiveness

contour

Specification:10 mg vial

Early research indicates significant promise for its dual role in appetite regulation and metabolic enhancement, particularly for patients unresponsive to GLP-1 monotherapy